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Structure basis for the unique speciﬁcity
of medaka enteropeptidase light chain
Dear Editor,
Enteropeptidase (enterokinase, EC 3.4.21.9) is a serine
protease, which shows a speciﬁc cleavage of its substrates
at the C-terminal of the recognition site (Asp)4Lys (Zheng
et al., 2009). Because of the unique speciﬁcity, enteropep-
tidase could be used as a tool for the production of recom-
binant fusion proteins. Especially the recombinant
enteropeptidase light chain (EPL), which contains a catalytic
domain, is of large interest to be applied in biopharmaceu-
tical industry (Lu et al., 1997).
Enteropeptidase has been cloned from several sources,
including bovine (Kitamoto et al., 1994), porcine (Matsushima
et al., 1994), humans (Kitamoto et al., 1995), mouse (Yuan
et al., 1998), and rat (Yahagi et al., 1996). For the high avail-
ability, the recombinant bovine enteropeptidase light chain
(BEPL) is nowmost commonly used. However, it is known that
BEPL does not exhibit high stringency in its speciﬁcity for the
canonical target sequenceD4K (Liewetal., 2007).For instance,
Shahravanet al. showed thatBEPLalsocleavedat unexpected
DR and SR sites in AhR6-C/EBP protein (Shahravan et al.,
2008). Recently, the enteropeptidase from medaka had been
reported to be amore effective tool, because of itsmuch stricter
speciﬁc for the D4K sequence compared to its mammalian
counterparts (Ogiwara and Takahashi, 2007). Therefore, we
sought to solve the crystal structure of the light chain ofmedaka
enteropeptidase (MEPL), and gain insights into the determi-
nants for its stricter speciﬁcity.
MEPL shares high sequence similarity with other EPL
classes, which have been structurally identiﬁed in previous
reports (Fig. S1). Therefore, the crystal structure of MEPL
was determined by molecular replacement using the bovine
enteropeptidase light chain (PDB entry 1EKB, 53.7% amino
acid identity) as the search model and reﬁned to 2.0 Å res-
olution. The structure of MEPL displays a typical α/β trypsin
—like serine protease fold (Fig. 1A). It consists of two six-
stranded β-barrels (β1–β6 and β7–β12), either of which
makes up about one half of the entire molecule. Both β-
barrels are arranged in a Greek-key-pattern containing α-
helices at the middle of each barrel with a third α-helix
located at the C-terminus. The surface potentials of MEPL
reveal an equal distribution of charged amino acids on pro-
tein surface although the region near the active center has a
predominantly negative potential (Fig. 1B).
Superimposing of MEPL with the bovine enteropeptidase
light chain resulted in an rmsd of 0.79 Å for the Ca coordi-
nates (Fig. 1C). The differences are mainly located in the
loop regions, such as the so-called ‘131-loop’ that connects
strand β7 and β8. MEPL also contains, relative to bovine
enzyme, an additional small 310-helix between the strand β4
and β5. Furthermore, the catalytic triad of the unliganded
medaka enteropeptidase superimposes well with the bovine
enzyme in complex with a trypsinogen-activation peptide
analogue (Lu et al., 1999). However, in secondary structure,
the active centers do not show any obvious differences
between the two enzymes, which intimates that the stricter
speciﬁcity of MEPL may depend on the distinct amino acid
sequence and unique intramolecular interactions.
The comparison of the catalytic centers between MEPL,
BEPL and HEPL (human enteropeptidase light chain, PDB
entry 4DGJ, amino acid identity 55%), provide an under-
standing of the mechanism of substrate speciﬁcity func-
tioned by these different enzymes (Fig. 2A and 2B).
In the structure of BEPL with a trypsinogen-activation
peptide (VD4K), the side chain of Lys-P1 inserts deeply into
a speciﬁc pocket, at the bottom of which Asp181 neutralizes
the terminal amino group (amino acid residues of peptidyl
substrates customarily are numbered P1, P2, P3, etc.
(Schechter and Berger, 1967)). The structure of this cleft
determinates that the P1 site of substrates could only be
lysine or arginine (Lu et al., 1999). This speciﬁc pocket
consists of three parts: the strand β11, the so called “174-
loop” that connects strand β9 and β10, and the “208-loop”
that connects strand β11 and β12. The main differences
locate at the N-terminus of “208-loop”, while the sequences
of strand β11 and “174-loop” are highly conservative. Com-
pared with BEPL and HEPL, MEPL shows much less activity
for the peptide substrates with arginine at P1 site, which
indicates its restriction for the entrance of arginine residues.
And according to the structural details, we supposed that the
variations of MEPLH24, MEPLE136, MEPLV209, MEPLG210 and
MEPLR213 may play curial role in the tension changes of the
loop chains around the pocket of catalytic center.
In MEPL structure, MEPLE136 makes three hydrogen
bonds with MEPLR213, while there are no similar interac-
tions in BEPL because it is BEPLL213, BEPLY136 in these
positions as well as the same situation for the HEPL
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structure (Fig. 2A). Although the interactions are a little far
distance from the catalytic center (8 Å), these hydrogen
bonds may help anchoring the “208-loop”, restricting the
electron density size of substrate. In addition, MEPLV209
and MEPLG210 with short side chains are covered and ﬁxed
by the side chains of four residues (MEPLE136, MEPLE163,
MEPLR213 and MEPLR216), reducing the mobility of “208-
loop” and strand β11 in MEPL. However, the amino acid
residues at the same positions in BEPL and HEPL are
exposed on the surface of the proteins, and therefore
possess higher ﬂexibility (Figs. 2A and S2). Moreover, we
observed that the imidazole group of MEPLH24 could form a
hydrogen bond with the main chain oxygen atom of
MEPLG185, which could help improving the structural rigidity
of “174-loop” (Fig. 2B). Nevertheless, there are no such
interactions in BEPL and HEPL because it is BEPLQ24 and
HEPLL24 at this position, respectively. Over all, the unique
residue interactions in MEPL may reduce the ﬂexibility of
the speciﬁc pocket, restricting the entrance of arginine
residue which has larger side chain.
In order to study the impacts of these residues on MEKL-
substrate interaction, 3 residues in MEPL were replaced by
those in BEPL respectively (H24Q, E136Y and R213L), and

























Figure 1. Structure of MEPL. (A) Overall structure of MEPL. The structure of MEPL is shown as ribbon diagrams in two orientations:
Front view, looking into the catalytic center; side view, besides the catalytic center. The MEPL molecules are colored as blue-white
and several key residues have been labeled. (B) Surface representation and vacuum electrostatic potential of MEPL (where red =
electronegative, white = neutral, blue = electropositive). (C) Structural variations of enteropeptidases. A single enteropeptidase
molecular of medaka, bovine, and human are shown. The medaka enteropeptidase molecule is colored blue-white, the bovine
enteropeptidase is colored salmon, and the human enteropeptidase is colored yellow, respectively. Structural variations are shown
with Red Box. Residues in the catalytic center are show in stick. The residues have been renumbered according to the sequence of
MEPL.
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speciﬁc activities of the four variants were assayed by using
the speciﬁc substrate GD4K-βNA and the non-speciﬁc sub-
strates Boc-E(OBzl)-AR-MCA and Z-FR-MCA. The results
showed that three mutants (H24Q, R213L and E136Y/
R213L) exhibited signiﬁcantly increased activity for the MCA-
containing substrates, while retaining GD4K-βNA hydrolyz-
ing activity (Fig. 2C and 2D). This result indicated the
importance of the two interactions (H24-G185 and E136-
R213) for the speciﬁcity of enteropeptidase. Nevertheless,
these mutations did not raise the activities of MEPL on
unspeciﬁc substrates to the level of BEPL, which meant
there should be other facts affecting the substrate-selectivity
of MEPL. The low enzyme activity of mutant E136Y for both
GD4K-βNA and the MCA-containing substrates meant that
the amino acids in position 136 might affect the activity of
enteropeptidase. And it was also been provided by the
kinetic studies (Table S3).
Taken together, our data on cleavage of peptide sub-
strates, faithfully supported by crystal structures, present an
extraordinary example of ﬁne adjustment of enzyme mech-
anism. Of note, this ﬁnding can be directly applied in the
reengineering of other enteropeptidases, for instance BEPL
and HEPL, to improve the speciﬁcity.
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Figure 2. Comparison of the catalytic center in MEPL, BEPL and HEPL, and speciﬁc assay of MEPL variants. (A and B) View
of detailed two regions considered as playing crucial role in the speciﬁcity mechanism. Key residues are shown as colored sticks
(blue-white MEPL, salmon BEPL and yellow HEPL, respectively). (C) Recombinant MEPL variants were assayed by using GD4K-
βNA as speciﬁc substrate. (D) Recombinant MEPL variants were assayed by using Z-FR-MCA and Boc-E(OBzl)-AR-MCA as
unspeciﬁc substrates.
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